✦ LIBER ✦

Genomics and Cardiovascular Drug Development

✍ Scribed by Andrew S. Plump; Pek Yee Lum

Book ID: 119268005
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 945 KB
Volume: 53
Category: Article
ISSN: 1558-3597
DOI: 10.1016/j.jacc.2008.11.050

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Expression genomics and cancer drug deve

Expression genomics and cancer drug development

✍ Edison T. Liu 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB

6 Genomics and proteomics in drug develo

6 Genomics and proteomics in drug development

✍ P. Workman 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 90 KB

Integrating genomics across drug discove

Integrating genomics across drug discovery and development

✍ Christine Debouck 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 137 KB

Chemical genomics versus orthodox drug d

Chemical genomics versus orthodox drug development

✍ David E. Szymkowski 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 37 KB

Application of genetics and genomics in

Application of genetics and genomics in drug development

✍ Mihael H. Polymeropoulos 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 54 KB 👁 2 views

Pharmacogenetics is capitalizing on the tools of the Human Genome Project to introduce the new genomic information into drug development. The applications vary from identifying individuals at risk for a disease, to developing gene signatures of drug efficacy and adverse effects. Pharmacogenetics is

Cardiovascular safety and diabetes drug

Cardiovascular safety and diabetes drug development

✍ Daniel J Drucker; Allison B Goldfine 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 349 KB